HAYRI SANGIRAY: Open Payments
NPI 1760596803 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 37 payments from 11 companies in 2025. Trend: 2023 $1,969 · 2024 $2,094 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $245 |
| GENZYME CORPORATION | 4 | $119 |
| Amgen Inc. | 5 | $110 |
| Organon LLC | 3 | $53 |
| Galderma Laboratories, L.P. | 3 | $49 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $38 |
| Lilly USA, LLC | 1 | $29 |
| Janssen Biotech, Inc. | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Incyte Corporation | 1 | $18 |
Products named: SKYRIZI, DUPIXENT, OTEZLA, NEMLUVIO, ILUMYA, RINVOQ, TALTZ, TREMFYA.
Industry payments across VA — which companies pay providers there.
